Literature DB >> 11159952

Study of Staphylococcus aureus pathogenic genes by transfer and expression in the less virulent organism Streptococcus gordonii.

P Stutzmann Meier1, J M Entenza, P Vaudaux, P Francioli, M P Glauser, P Moreillon.   

Abstract

Because Staphylococcus aureus strains contain multiple virulence factors, studying their pathogenic role by single-gene inactivation generated equivocal results. To circumvent this problem, we have expressed specific S. aureus genes in the less virulent organism Streptococcus gordonii and tested the recombinants for a gain of function both in vitro and in vivo. Clumping factor A (ClfA) and coagulase were investigated. Both gene products were expressed functionally and with similar kinetics during growth by streptococci and staphylococci. ClfA-positive S. gordonii was more adherent to platelet-fibrin clots mimicking cardiac vegetations in vitro and more infective in rats with experimental endocarditis (P < 0.05). Moreover, deleting clfA from clfA-positive streptococcal transformants restored both the low in vitro adherence and the low in vivo infectivity of the parent. Coagulase-positive transformants, on the other hand, were neither more adherent nor more infective than the parent. Furthermore, coagulase did not increase the pathogenicity of clfA-positive streptococci when both clfA and coa genes were simultaneously expressed in an artificial minioperon in streptococci. These results definitively attribute a role for ClfA, but not coagulase, in S. aureus endovascular infections. This gain-of-function strategy might help solve the role of individual factors in the complex the S. aureus-host relationship.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11159952      PMCID: PMC97936          DOI: 10.1128/IAI.69.2.657-664.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

1.  Method and parameters for genetic transformation of Streptococcus sanguis Challis.

Authors:  G Pozzi; R A Musmanno; P M Lievens; M R Oggioni; P Plevani; R Manganelli
Journal:  Res Microbiol       Date:  1990 Jul-Aug       Impact factor: 3.992

2.  The alternative sigma factor sigmaB in Staphylococcus aureus: regulation of the sigB operon in response to growth phase and heat shock

Authors: 
Journal:  Arch Microbiol       Date:  1997-03-07       Impact factor: 2.552

3.  Interaction of human fibrinogen with staphylococci: presence of a binding region on normal and abnormal fibrinogen variants and fibrinogen derivatives.

Authors:  J Hawiger; D K Hammond; S Timmons; A Z Budzynski
Journal:  Blood       Date:  1978-05       Impact factor: 22.113

4.  Expression of Staphylococcus aureus clumping factor A in Lactococcus lactis subsp. cremoris using a new shuttle vector.

Authors:  Y A Que; J A Haefliger; P Francioli; P Moreillon
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

5.  Hyperproduction of alpha-toxin by Staphylococcus aureus results in paradoxically reduced virulence in experimental endocarditis: a host defense role for platelet microbicidal proteins.

Authors:  A S Bayer; M D Ramos; B E Menzies; M R Yeaman; A J Shen; A L Cheung
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

6.  Diminished virulence of a sar-/agr- mutant of Staphylococcus aureus in the rabbit model of endocarditis.

Authors:  A L Cheung; K J Eberhardt; E Chung; M R Yeaman; P M Sullam; M Ramos; A S Bayer
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

7.  Role of the accessory gene regulator (agr) in pathogenesis of staphylococcal osteomyelitis.

Authors:  A F Gillaspy; S G Hickmon; R A Skinner; J R Thomas; C L Nelson; M S Smeltzer
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

8.  Clumping factor B (ClfB), a new surface-located fibrinogen-binding adhesin of Staphylococcus aureus.

Authors:  D Ní Eidhin; S Perkins; P Francois; P Vaudaux; M Höök; T J Foster
Journal:  Mol Microbiol       Date:  1998-10       Impact factor: 3.501

9.  Novel shuttle plasmid vehicles for Escherichia-Streptococcus transgeneric cloning.

Authors:  F L Macrina; R P Evans; J A Tobian; D L Hartley; D B Clewell; K R Jones
Journal:  Gene       Date:  1983-11       Impact factor: 3.688

10.  Reconsideration of the role of fibronectin binding in endocarditis caused by Staphylococcus aureus.

Authors:  J I Flock; S A Hienz; A Heimdahl; T Schennings
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

View more
  19 in total

1.  Open-label, dose escalation study of the safety and pharmacokinetic profile of tefibazumab in healthy volunteers.

Authors:  Sandra Reilley; Eric Wenzel; Laurie Reynolds; Beth Bennett; Joseph M Patti; Seth Hetherington
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

2.  Characterization of a humanized monoclonal antibody recognizing clumping factor A expressed by Staphylococcus aureus.

Authors:  Paul J Domanski; Pratiksha R Patel; Arnold S Bayer; Li Zhang; Andrea E Hall; Peter J Syribeys; Elena L Gorovits; Dawn Bryant; John H Vernachio; Jeff T Hutchins; Joseph M Patti
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

3.  Reassessing the role of Staphylococcus aureus clumping factor and fibronectin-binding protein by expression in Lactococcus lactis.

Authors:  Y A Que; P François; J A Haefliger; J M Entenza; P Vaudaux; P Moreillon
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

4.  Identification and characterization of a novel 38.5-kilodalton cell surface protein of Staphylococcus aureus with extended-spectrum binding activity for extracellular matrix and plasma proteins.

Authors:  M Hussain; K Becker; C von Eiff; J Schrenzel; G Peters; M Herrmann
Journal:  J Bacteriol       Date:  2001-12       Impact factor: 3.490

5.  Role of sigmaB in the expression of Staphylococcus aureus cell wall adhesins ClfA and FnbA and contribution to infectivity in a rat model of experimental endocarditis.

Authors:  Jose-Manuel Entenza; Philippe Moreillon; Maria Magdalena Senn; Jan Kormanec; Paul M Dunman; Brigitte Berger-Bächi; Steven Projan; Markus Bischoff
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

6.  Analysis of Ebh, a 1.1-megadalton cell wall-associated fibronectin-binding protein of Staphylococcus aureus.

Authors:  Simon R Clarke; Llinos G Harris; R Geoff Richards; Simon J Foster
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

Review 7.  Staphylococcus aureus Aggregation and Coagulation Mechanisms, and Their Function in Host-Pathogen Interactions.

Authors:  H A Crosby; J Kwiecinski; A R Horswill
Journal:  Adv Appl Microbiol       Date:  2016-08-04       Impact factor: 5.086

8.  Functional blocking of Staphylococcus aureus adhesins following growth in ex vivo media.

Authors:  Ruth C Massey; Shobana R Dissanayeke; Brian Cameron; David Ferguson; Timothy J Foster; Sharon J Peacock
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

9.  Anti-clumping factor A immunoglobulin reduces the duration of methicillin-resistant Staphylococcus aureus bacteremia in an experimental model of infective endocarditis.

Authors:  John Vernachio; Arnold S Bayer; Thuan Le; Yin-Li Chai; Bradley Prater; Amy Schneider; Brenda Ames; Peter Syribeys; Jeffrey Robbins; Joseph M Patti
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

10.  Characterization of a protective monoclonal antibody recognizing Staphylococcus aureus MSCRAMM protein clumping factor A.

Authors:  Andrea E Hall; Paul J Domanski; Pratiksha R Patel; John H Vernachio; Peter J Syribeys; Elena L Gorovits; Michael A Johnson; Julia M Ross; Jeff T Hutchins; Joseph M Patti
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.